542 related articles for article (PubMed ID: 33448750)
1. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
2. Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.
de Graaf JA; Kuijpers M; Visser-Meily J; Kappelle LJ; Post M
Clin Rehabil; 2020 Apr; 34(4):545-550. PubMed ID: 32070131
[TBL] [Abstract][Full Text] [Related]
3. Validity of the Utrecht scale for evaluation of rehabilitation-participation restrictions scale in a hospital-based stroke population 3 months after stroke.
de Graaf JA; Volkers EJ; Schepers VPM; Visser-Meily JMA; Post MWM
Top Stroke Rehabil; 2022 Oct; 29(7):516-525. PubMed ID: 34315356
[TBL] [Abstract][Full Text] [Related]
4. A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 and PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample.
Rencz F; Brodszky V; Janssen MF
Value Health; 2023 Jul; 26(7):1045-1056. PubMed ID: 36804583
[TBL] [Abstract][Full Text] [Related]
5. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
6. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.
Lin FJ; Pickard AS; Krishnan JA; Joo MJ; Au DH; Carson SS; Gillespie S; Henderson AG; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Vollmer WM; Lee TA;
BMC Med Res Methodol; 2014 Jun; 14():78. PubMed ID: 24934150
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany.
Klapproth CP; Sidey-Gibbons CJ; Valderas JM; Rose M; Fischer F
Value Health; 2022 May; 25(5):824-834. PubMed ID: 35500951
[TBL] [Abstract][Full Text] [Related]
8. Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr.
Mulhern BJ; Pan T; Norman R; Tran-Duy A; Hanmer J; Viney R; Devlin NJ
Qual Life Res; 2023 Nov; 32(11):3147-3160. PubMed ID: 37347395
[TBL] [Abstract][Full Text] [Related]
9. Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients: an analysis of measurement properties.
Schmidt J; Düvel JA; Elkenkamp S; Greiner W
Health Qual Life Outcomes; 2024 Jun; 22(1):45. PubMed ID: 38835023
[TBL] [Abstract][Full Text] [Related]
10. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
11. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
12. Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany.
Klapproth CP; van Bebber J; Sidey-Gibbons CJ; Valderas JM; Leplege A; Rose M; Fischer F
Health Qual Life Outcomes; 2020 Dec; 18(1):389. PubMed ID: 33334351
[TBL] [Abstract][Full Text] [Related]
13. Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy.
Xu RH; Ma B; Xin H; Zhang H; Zeng Y; Luo N; Dong D
Health Qual Life Outcomes; 2023 Nov; 21(1):123. PubMed ID: 37968716
[TBL] [Abstract][Full Text] [Related]
14. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
15. Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study.
Wæhler IS; Saltvedt I; Lydersen S; Fure B; Askim T; Einstad MS; Thingstad P
BMC Neurol; 2021 Mar; 21(1):100. PubMed ID: 33663430
[TBL] [Abstract][Full Text] [Related]
16. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
[TBL] [Abstract][Full Text] [Related]
17. Comparative responsiveness of the PROMIS-10 Global Health and EQ-5D questionnaires in patients undergoing total knee arthroplasty.
Shim J; Hamilton DF
Bone Joint J; 2019 Jul; 101-B(7):832-837. PubMed ID: 31256677
[TBL] [Abstract][Full Text] [Related]
18. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
19. Performance of PROMIS Global-10 Compared With Legacy Instruments for Rotator Cuff Disease.
Nicholson AD; Kassam HF; Pan SD; Berman JE; Blaine TA; Kovacevic D
Am J Sports Med; 2019 Jan; 47(1):181-188. PubMed ID: 30481472
[TBL] [Abstract][Full Text] [Related]
20. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
